Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00221832
Status:
UNKNOWN
Last Update Posted:
2010-01-13
First Post:
2005-09-14
Brief Title:
Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases
Sponsor:
Heidelberg University
Organization:
Heidelberg University
Study Overview
Official Title:
Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases
Status:
UNKNOWN
Status Verified Date:
2003-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is the identification of familial congenital arrhythmogenic disorders and their clinical follow-up
Detailed Description:
Molecular genetic screening in patients with
supraventricular
ventricular arrhythmia
syncopes of unknown origin andor suspicion of an arrhythmogenic origin
family members of patients with sudden cardiac death and aborted sudden cardiac death
Examination of patients includes routine testing like electrocardiogram ECG sequential ECGs exercise testing invasive electrophysiological stimulation cardiac magnetic resonance imaging intravenous drug challenge for identificationexclusion of eg Brugada syndrome Examples are patients with Long QT Syndrome Short QT Syndrome Brugada Syndrome familial atrial fibrillation WPW-syndrome arrhythmias due to familial hypertrophic cardiomyopathy or arrhythmogenic right ventricular dysplasia Blood samples are taken for further molecular genetic screening
supraventricular
ventricular arrhythmia
syncopes of unknown origin andor suspicion of an arrhythmogenic origin
family members of patients with sudden cardiac death and aborted sudden cardiac death
Examination of patients includes routine testing like electrocardiogram ECG sequential ECGs exercise testing invasive electrophysiological stimulation cardiac magnetic resonance imaging intravenous drug challenge for identificationexclusion of eg Brugada syndrome Examples are patients with Long QT Syndrome Short QT Syndrome Brugada Syndrome familial atrial fibrillation WPW-syndrome arrhythmias due to familial hypertrophic cardiomyopathy or arrhythmogenic right ventricular dysplasia Blood samples are taken for further molecular genetic screening
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None